|Title||Legal Authority for Emergency Medical Services to Increase Access to Buprenorphine Treatment for Opioid Use Disorder.|
|Publication Type||Journal Article|
|Year of Publication||2021|
|Authors||Davis CS, Carr DH, Glenn MJ, Samuels EA|
|Journal||Ann Emerg Med|
|Date Published||2021 07|
|Keywords||Buprenorphine, Drug Overdose, Emergency Medical Services, Humans, Narcotic Antagonists, Opiate Substitution Treatment, Opioid-Related Disorders, United States|
Treatment with buprenorphine significantly reduces both all-cause and overdose mortality among individuals with opioid use disorder. Offering buprenorphine treatment to individuals who experience a nonfatal opioid overdose represents an opportunity to reduce opioid overdose fatalities. Although some emergency departments (EDs) initiate buprenorphine treatment, many individuals who experience an overdose either refuse transport to the ED or are transported to an ED that does not offer buprenorphine. Emergency medical services (EMS) professionals can help address this treatment gap. In this Concepts article, we describe the federal legal landscape that governs the ability of EMS professionals to administer buprenorphine treatment, and discuss state and local regulatory considerations relevant to this promising and emerging practice.
|Alternate Journal||Ann Emerg Med|
|PubMed Central ID||PMC8238848|
|Grant List||U54 GM115677 / GM / NIGMS NIH HHS / United States|
Legal Authority for Emergency Medical Services to Increase Access to Buprenorphine Treatment for Opioid Use Disorder.
Melody J. Glenn, MD, MFA